Genentech
RITUXAN HYCELA
Manufacturer:
Genentech
Name:
RITUXAN HYCELA
HCPCS Code Descriptor:
Injection, rituximab 10 mg and hyaluronidase
Category:
J Code
HCPCS:
J9311
NDC(s):
50242-0108-01, 50242-0109-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Subcutaneous
About:
RITUXAN HYCELA is an Oncology drug manufactured by Genentech and administered via the Subcutaneous route of administration. The J Code: J9311 is aligned to the drug RITUXAN HYCELA.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/19
HCPCS Effective Date:
1/1/19
HCPCS Short Description:
Inj rituximab, hyaluronidase
Billing and Coding Guide:
https://www.rituxanhycela.com/content/dam/gene/accesssolutions/pdfs/coding/Rituxan-HYCELA-Billing-Coding-for-FL.pdf
Patient Assistance:
Not Found